These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 26199318)

  • 1. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.
    Fargue S; Rumsby G; Danpure CJ
    Biochim Biophys Acta; 2013 Oct; 1832(10):1776-83. PubMed ID: 23597595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B
    Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
    Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
    Montioli R; Oppici E; Dindo M; Roncador A; Gotte G; Cellini B; Borri Voltattorni C
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1280-9. PubMed ID: 26149463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB; Lian Q; Wong SG
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
    Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
    Cellini B; Montioli R; Paiardini A; Lorenzetto A; Voltattorni CB
    J Biol Chem; 2009 Mar; 284(13):8349-58. PubMed ID: 19155213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
    Fargue S; Lewin J; Rumsby G; Danpure CJ
    J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1.
    Gatticchi L; Dindo M; Pampalone G; Conter C; Cellini B; Takayama T
    Biochem Biophys Res Commun; 2023 Feb; 645():118-123. PubMed ID: 36682331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Pyridoxamine and Pyridoxal are More Effective than Pyridoxine in Rescuing Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
    Assimos DG
    J Urol; 2016 Apr; 195(4 Pt 1):1170-1. PubMed ID: 27302825
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular insights into primary hyperoxaluria type 1 pathogenesis.
    Cellini B; Oppici E; Paiardini A; Montioli R
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):621-34. PubMed ID: 22201765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.
    Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
    Lumb MJ; Danpure CJ
    J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Maccari L; Porcari V; Lorenzetto A; Chellini S; Voltattorni CB; Cellini B
    ACS Chem Biol; 2015 Oct; 10(10):2227-36. PubMed ID: 26161999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
    Pey AL; Salido E; Sanchez-Ruiz JM
    Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
    Oppici E; Montioli R; Cellini B
    Biochim Biophys Acta; 2015 Sep; 1854(9):1212-9. PubMed ID: 25620715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
    Oppici E; Montioli R; Lorenzetto A; Bianconi S; Borri Voltattorni C; Cellini B
    Mol Genet Metab; 2012 Jan; 105(1):132-40. PubMed ID: 22018727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization.
    Dindo M; Mandrile G; Conter C; Montone R; Giachino D; Pelle A; Costantini C; Cellini B
    Mol Genet Metab; 2020; 131(1-2):171-180. PubMed ID: 32792227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.